Dr. Martin Gundersen, Technical Advisor and Board Member to Kairos Ventures portfolio company Transient Plasma Systems, has been awarded...

Read more
By: Kairos Ventures On: February 25, 2018 In: nFugue, Portfolio News

Founded in 2018 nFugue is nanostructures company that is leading in the precision architecting of materials at the nano-scale....

Read more
By: Kairos Ventures On: January 29, 2018 In: Portfolio News, Sienza Energy

We are thrilled that Sienza Energy is the latest company to join the Kairos portfolio. Sienza Energy is a...

Read more
By: Kairos Ventures On: January 3, 2018 In: Portfolio News, Symbiotix

We are pleased to announce that our portfolio company Symbiotix has entered into a process development and manufacturing agreement...

Read more

Kairos Ventures portfolio company Axial Biotherapeutics announced the appointment of Dr. Gregory T. Bates as Senior Vice President of...

Read more
By: Kairos Ventures On: November 6, 2017 In: Portfolio News, Provivi

We are pleased to announce that our portfolio company Provivi, Inc. closed on the first $21 million of a...

Read more
By: Kairos Ventures On: November 1, 2017 In: Portfolio News, Symbiotix

We are pleased to announce that Symbiotix Biotherapies, Inc. is the latest company to join the Kairos portfolio. Founded in...

Read more
By: Kairos Ventures On: October 8, 2017 In: MixComm, Portfolio News

We are delighted to announce that MixComm Inc. is the latest company to join the Kairos portfolio. MixComm Inc....

Read more

Founded in 2017 Opera Therapeutics is a biopharmaceutical company that is developing next-generation treatments for ocular and neurological diseases.

Read more
By: Kairos Ventures On: September 29, 2017 In: Auspion, Portfolio News

We are thrilled to announce that Auspion Inc. has joined the Kairos Portfolio. Auspion, Inc. is a wireless communications...

Read more